Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrence.
Ushimaru Y, Takahashi T, Nakajima K, Teranishi R, Nishida T, Hirota S, Motoori M, Omori T, Kawabata R, Nishikawa K, Saito T, Yamashita K, Tanaka K, Makino T, Yamamoto K, Kurokawa Y, Eguchi H, Doki Y.
Ushimaru Y, et al. Among authors: nakajima k.
Int J Clin Oncol. 2022 May;27(5):921-929. doi: 10.1007/s10147-022-02135-7. Epub 2022 Feb 12.
Int J Clin Oncol. 2022.
PMID: 35152356